Zymergen Raises $130M in Series C
Zymergen has successfully raised $130M in a Series C at a $560M valuation led by SoftBank Vision Fund, Data Collective.
Company Overview
Zymergen is a Biotech company headquartered in Emeryville, CA, founded in 2013 with 500+ employees.
Bio-based materials and molecule development
Fundraising Details
- Amount Raised: $130M
- Round Type: Series C
- Valuation: $560M
- Date: 2018-12-04
- Investors: SoftBank Vision Fund, Data Collective
About Zymergen
Bio-based materials and molecule development The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Emeryville, CA
- Founded: 2013
- Team Size: 500+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Zymergen's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Zymergen's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $560M valuation marks an important milestone for Zymergen, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Zymergen is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2018-12-04. For more information about Zymergen, visit their headquarters at Emeryville, CA.
